# REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia

> **NCT07270575** · — · NOT_YET_RECRUITING · sponsor: **Cardiovascular and Interventional Radiological Society of Europe** · enrollment: 400 (estimated)

## Conditions studied

- Chronic Limb Threatening Ischemia
- Chronic Limb-Threatening Ischemia

## Interventions

- **DEVICE:** Esprit BTK™ Everolimus Eluting Resorbable Scaffold from Abbott

## Key facts

- **NCT ID:** NCT07270575
- **Lead sponsor:** Cardiovascular and Interventional Radiological Society of Europe
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2032-04
- **Final completion:** 2032-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07270575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07270575, "REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07270575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*